| MalariaWorld Newsletter - publishing date: 06/24/2011 Latest scientific publications: Jun 23, 2011 05:05 pm | Bart Knols Jun 23, 2011 10:53 am | patrick sampao Jun 23, 2011 10:14 am | Kabogo Jun 23, 2011 10:08 am | Kabogo Jun 23, 2011 03:25 am | Kabogo Jun 23, 2011 03:02 am | Kabogo Jun 23, 2011 02:59 am | Kabogo Jun 23, 2011 02:51 am | Kabogo Jun 23, 2011 02:43 am | Kabogo Jun 22, 2011 10:53 am | patrick sampao Jun 22, 2011 10:30 am | patrick sampao Jun 22, 2011 10:17 am | patrick sampao Jun 22, 2011 03:06 am | Kabogo Jun 22, 2011 03:00 am | Kabogo Jun 22, 2011 02:50 am | Kabogo Jun 21, 2011 10:23 am | patrick sampao Jun 21, 2011 10:05 am | patrick sampao Jun 21, 2011 09:55 am | Kabogo Jun 21, 2011 09:49 am | Kabogo Jun 21, 2011 09:48 am | patrick sampao Jun 21, 2011 09:01 am | Kabogo Jun 21, 2011 03:27 am | Kabogo Jun 21, 2011 03:15 am | Kabogo Jun 21, 2011 03:08 am | Kabogo Jun 21, 2011 02:55 am | Kabogo Jun 21, 2011 02:51 am | Kabogo Jun 21, 2011 02:47 am | Kabogo Jun 20, 2011 10:21 am | patrick sampao Jun 20, 2011 10:16 am | patrick sampao Jun 18, 2011 11:09 am | Kabogo Jun 18, 2011 11:05 am | Kabogo Jun 18, 2011 10:09 am | patrick sampao Jun 18, 2011 09:54 am | patrick sampao Jun 18, 2011 09:32 am | patrick sampao |
Showing posts with label malaria. Show all posts
Showing posts with label malaria. Show all posts
Wednesday, July 20, 2011
Monday, July 18, 2011
George Clooney Contracted Malaria in the Sudan... Again
latimes.com/health/boostershots/la-heb-george-clooney-201101,0,4348566.story
Source: latimes.com
George Clooney contracted malaria on Sudan visit -- and recovered, media reports say
By Mary Forgione, Tribune Health - January 20, 2011
George Clooney has perhaps learned an important lesson -- malaria makes traveling the globe a lot less fun than it should be.
Sure, it’s noble to go on philanthropic missions around the world, helping those who can’t help themselves, but it’s probably hard to feel noble when shaking from the chills. And Clooney should know. The actor apparently has just recovered from malaria, which he contracted in Africa earlier this month, media reports said Thursday.
CNN’s Piers Morgan on Wednesday night tweeted that Clooney was fighting the illness and posts this clip of the actor talking about his condition. Clooney apparently got the disease for a second time while in southern Sudan during the pivotal election for independence. People magazine ran a statement from a spokesman Thursday saying the actor is completely over the illness.
Malaria is a serious, sometimes fatal disease contracted by a mosquito bite, the Centers for Disease Control and Prevention says. And Clooney's illness highlights the risk that travelers face. Symptoms include high fevers, shaking chills, and flu-like illness. So take care -- take preventive drugs such as chloroquine phosphate and mefloquine before you go. Here's more information from the CDC.
The World Health Organization reports a risk of malaria in more than 100 countries and says about 30,000 international travelers get the disease each year. It also offers these tips:
"A. Be Aware of the risk, the incubation period and the main symptoms.
B. Avoid being Bitten by mosquitoes, especially between dusk and dawn.
C. Take antimalarial drugs ... to suppress infection where appropriate. D. Immediately seek diagnosis and treatment if a fever develops one week or more after entering an area where there is a malaria risk, and up to 3 months after departure."
So back to Clooney. He is scheduled to appear on Morgan’s show Friday night -- and talk about this recent bout with malaria.
Copyright © 2011, Los Angeles Times
Source: latimes.com
George Clooney contracted malaria on Sudan visit -- and recovered, media reports say
By Mary Forgione, Tribune Health - January 20, 2011
George Clooney has perhaps learned an important lesson -- malaria makes traveling the globe a lot less fun than it should be.
Sure, it’s noble to go on philanthropic missions around the world, helping those who can’t help themselves, but it’s probably hard to feel noble when shaking from the chills. And Clooney should know. The actor apparently has just recovered from malaria, which he contracted in Africa earlier this month, media reports said Thursday.
CNN’s Piers Morgan on Wednesday night tweeted that Clooney was fighting the illness and posts this clip of the actor talking about his condition. Clooney apparently got the disease for a second time while in southern Sudan during the pivotal election for independence. People magazine ran a statement from a spokesman Thursday saying the actor is completely over the illness.
Malaria is a serious, sometimes fatal disease contracted by a mosquito bite, the Centers for Disease Control and Prevention says. And Clooney's illness highlights the risk that travelers face. Symptoms include high fevers, shaking chills, and flu-like illness. So take care -- take preventive drugs such as chloroquine phosphate and mefloquine before you go. Here's more information from the CDC.
The World Health Organization reports a risk of malaria in more than 100 countries and says about 30,000 international travelers get the disease each year. It also offers these tips:
"A. Be Aware of the risk, the incubation period and the main symptoms.
B. Avoid being Bitten by mosquitoes, especially between dusk and dawn.
C. Take antimalarial drugs ... to suppress infection where appropriate. D. Immediately seek diagnosis and treatment if a fever develops one week or more after entering an area where there is a malaria risk, and up to 3 months after departure."
So back to Clooney. He is scheduled to appear on Morgan’s show Friday night -- and talk about this recent bout with malaria.
Copyright © 2011, Los Angeles Times
Mosquito Subspecies Presents Challenge in Fighting Malaria
latimes.com/news/science/la-he-malaria-mosquito-20110204,0,3125160.story
Source: latimes.com
Mosquito subspecies presents challenge in fighting malaria
Efforts to wipe out the disease have focused on indoor mosquitoes, but a newly discovered type that's more susceptible to the parasite lives outdoors, where it's harder to battle.
By Amina Khan, Los Angeles Times
February 4, 2011
Researchers have discovered a previously unknown subspecies of mosquito in West Africa that is highly susceptible to the malaria parasite and whose existence may stymie efforts to eradicate the deadly disease.
Unlike the indoor-dwelling mosquitoes that are the usual targets of malaria eradication efforts, members of the newly described subgroup of the species Anopheles gambiae live outdoors, which means they're more difficult to kill, according to the study published online Thursday in the journal Science.
"We've got egg on our face," said William Black, a medical entomologist at Colorado State University who was not involved in the study. "We've been working with this mosquito for so long … and right under our noses, here's this other form of mosquito," he said — one that could force researchers "to start thinking about what's going on outside of those huts."
Malaria is an incurable blood disease caused by parasites in the genus Plasmodium. Mosquitoes spread the parasite by drawing blood from infected humans, becoming carriers themselves and then transmitting the parasite to other humans they bite.
Malaria victims suffer headaches, high fever, chills, vomiting, anemia and sometimes death. There are about 250 million cases and nearly 1 million deaths each year, according to the World Health Organization.
Anopheles gambiae is thought to be the most significant malaria transmitter in Africa, and it has resisted repeated efforts to wipe it out, said Kenneth Vernick, a vector geneticist at the Pasteur Institute in Paris who co-wrote the study. Malaria control projects going back to the 1970s have apparently failed because they used tactics such as indoor sprays and chemically treated bed netting that only targeted mosquitoes inside human homes.
One of the reasons for focusing on indoor insects "is that people imagine that mosquitoes that are in proximity to people might be the most epidemiologically important to transmit malaria," Vernick said. But there's another, less scientific reason as well, he added: "Because it's easy."
Outdoor mosquitoes, on the other hand, are notoriously difficult to kill, let alone capture to study in experiments. Without the benefit of walls and a roof, Vernick said, "you don't have a defined space to spray-bomb and catch them and have them fall on a sheet."
Instead of chasing after the adult insects, the researchers decided to search for them in the larval stage, when they're easier to capture. Mosquitoes breed close to human habitations in puddles of standing water that collects in tire-tracks or hoof prints, for example. In West Africa, standing bodies of water are hard to come by, so all types of mosquitoes would likely be forced to use common puddles to hatch their young.
The researchers traveled across Burkina Faso, collecting larvae from puddles around villages and growing thousands of mosquitoes over a four-year period. They genetically analyzed the young and found that only 43% of the larvae in the puddles were the indoor variety — meaning that 57% were not.
When the researchers fed the mosquitoes blood from humans who had malaria, 58% of the outdoor mosquitoes became infected with the parasite, compared with 35% of the indoor-resting ones.
Now scientists need to capture adult outdoor mosquitoes and study their feeding habits so they can determine whether the insects are a significant malaria threat, Black said. If so, he concluded, "it means we're going to have to change a lot of our control tactics."
amina.khan@latimes.com
Copyright © 2011, Los Angeles Times
Source: latimes.com
Mosquito subspecies presents challenge in fighting malaria
Efforts to wipe out the disease have focused on indoor mosquitoes, but a newly discovered type that's more susceptible to the parasite lives outdoors, where it's harder to battle.
By Amina Khan, Los Angeles Times
February 4, 2011
Researchers have discovered a previously unknown subspecies of mosquito in West Africa that is highly susceptible to the malaria parasite and whose existence may stymie efforts to eradicate the deadly disease.
Unlike the indoor-dwelling mosquitoes that are the usual targets of malaria eradication efforts, members of the newly described subgroup of the species Anopheles gambiae live outdoors, which means they're more difficult to kill, according to the study published online Thursday in the journal Science.
"We've got egg on our face," said William Black, a medical entomologist at Colorado State University who was not involved in the study. "We've been working with this mosquito for so long … and right under our noses, here's this other form of mosquito," he said — one that could force researchers "to start thinking about what's going on outside of those huts."
Malaria is an incurable blood disease caused by parasites in the genus Plasmodium. Mosquitoes spread the parasite by drawing blood from infected humans, becoming carriers themselves and then transmitting the parasite to other humans they bite.
Malaria victims suffer headaches, high fever, chills, vomiting, anemia and sometimes death. There are about 250 million cases and nearly 1 million deaths each year, according to the World Health Organization.
Anopheles gambiae is thought to be the most significant malaria transmitter in Africa, and it has resisted repeated efforts to wipe it out, said Kenneth Vernick, a vector geneticist at the Pasteur Institute in Paris who co-wrote the study. Malaria control projects going back to the 1970s have apparently failed because they used tactics such as indoor sprays and chemically treated bed netting that only targeted mosquitoes inside human homes.
One of the reasons for focusing on indoor insects "is that people imagine that mosquitoes that are in proximity to people might be the most epidemiologically important to transmit malaria," Vernick said. But there's another, less scientific reason as well, he added: "Because it's easy."
Outdoor mosquitoes, on the other hand, are notoriously difficult to kill, let alone capture to study in experiments. Without the benefit of walls and a roof, Vernick said, "you don't have a defined space to spray-bomb and catch them and have them fall on a sheet."
Instead of chasing after the adult insects, the researchers decided to search for them in the larval stage, when they're easier to capture. Mosquitoes breed close to human habitations in puddles of standing water that collects in tire-tracks or hoof prints, for example. In West Africa, standing bodies of water are hard to come by, so all types of mosquitoes would likely be forced to use common puddles to hatch their young.
The researchers traveled across Burkina Faso, collecting larvae from puddles around villages and growing thousands of mosquitoes over a four-year period. They genetically analyzed the young and found that only 43% of the larvae in the puddles were the indoor variety — meaning that 57% were not.
When the researchers fed the mosquitoes blood from humans who had malaria, 58% of the outdoor mosquitoes became infected with the parasite, compared with 35% of the indoor-resting ones.
Now scientists need to capture adult outdoor mosquitoes and study their feeding habits so they can determine whether the insects are a significant malaria threat, Black said. If so, he concluded, "it means we're going to have to change a lot of our control tactics."
amina.khan@latimes.com
Copyright © 2011, Los Angeles Times
Unique Anti-malarial Gets a Foothold
Smell of stinky feet just what malaria doctor ordered
By Marni Jameson, Orlando Sentinel
July 14, 2011.
Want to fend off mosquitoes and ultimately malaria? Wash your feet, or set out stinky sock traps.
Turns out, the smellier your feet, the more mosquitoes — which spread malaria — like them and you. Such was the discovery made by brave Dutch scientist Bart Knols, who, in the interest of us all, stood naked in a dark, mosquito-filled room to find out which parts of him mosquitoes found most edible.
Hands down it was his feet. And the more odorous they were, the more mosquitoes liked them.
Fast forward 15 years, and a new swarm of scientists have taken the funky-foot finding a step further. They are using foot odor to help control malaria.
Dr. Fredros Okuma, a researcher for Tanzania's Ifakara Health Institute, has replicated the odor — a fragrant blend of eight chemicals — and has put it in traps that lure mosquitoes and poison them. The traps were four times more attractive to mosquitoes than a human volunteer.
The simple solution appears so promising that The Bill and Melinda Gates Foundation has awarded two grants totaling $865,000 to Okuma for research on how the traps can be made affordable and used to help prevent the spread of disease in Africa.
By Marni Jameson, Orlando Sentinel
July 14, 2011.
Want to fend off mosquitoes and ultimately malaria? Wash your feet, or set out stinky sock traps.
Turns out, the smellier your feet, the more mosquitoes — which spread malaria — like them and you. Such was the discovery made by brave Dutch scientist Bart Knols, who, in the interest of us all, stood naked in a dark, mosquito-filled room to find out which parts of him mosquitoes found most edible.
Hands down it was his feet. And the more odorous they were, the more mosquitoes liked them.
Fast forward 15 years, and a new swarm of scientists have taken the funky-foot finding a step further. They are using foot odor to help control malaria.
Dr. Fredros Okuma, a researcher for Tanzania's Ifakara Health Institute, has replicated the odor — a fragrant blend of eight chemicals — and has put it in traps that lure mosquitoes and poison them. The traps were four times more attractive to mosquitoes than a human volunteer.
The simple solution appears so promising that The Bill and Melinda Gates Foundation has awarded two grants totaling $865,000 to Okuma for research on how the traps can be made affordable and used to help prevent the spread of disease in Africa.
Sunday, July 17, 2011
Accuracy of malaria rapid diagnostic tests in community studies and their impact on treatment of malaria in an area with declining malaria burden in north-eastern Tanzania
Accuracy of malaria rapid diagnostic tests in community studies and their impact on treatment of malaria in an area with declining malaria burden in north-eastern Tanzania
Deus S Ishengoma, Filbert Francis, Bruno P Mmbando, John PA Lusingu, Pamela Magistrado, Michael Alifrangis, Thor G Theander, Ib C Bygbjerg and Martha M Lemnge
Malaria Journal 2011, 10:176doi:10.1186/1475-2875-10-176
| Published: | 26 June 2011 |
Abstract (provisional)
Background
Despite some problems related to accuracy and applicability of malaria rapid diagnostic tests (RDTs), they are currently the best option in areas with limited laboratory services for improving case management through parasitological diagnosis and reducing over-treatment. This study was conducted in areas with declining malaria burden to assess; 1) the accuracy of RDTs when used at different community settings, 2) the impact of using RDTs on anti-malarial dispensing by community-owned resource persons (CORPs) and 3) adherence of CORPs to treatment guidelines by providing treatment based on RDT results.
Methods
Data were obtained from: 1) a longitudinal study of passive case detection of fevers using CORPs in six villages in Korogwe; and 2) cross-sectional surveys (CSS) in six villages of Korogwe and Muheza districts, north-eastern, Tanzania. Performance of RDTs was compared with microscopy as a gold standard, and factors affecting their accuracy were explored using a multivariate logistic regression model.
Results
Overall sensitivity and specificity of RDTs in the longitudinal study (of 23,793 febrile cases; 18,154 with microscopy and RDTs results) were 88.6% and 88.2%, respectively. In the CSS, the sensitivity was significantly lower (63.4%; chi2=367.7, p<0.001), while the specificity was significantly higher (94.3%; chi2=143.1, p<0.001) when compared to the longitudinal study. As determinants of sensitivity of RDTs in both studies, parasite density of <200 asexual parasites/ul was significantly associated with high risk of false negative RDTs (OR[greater than or equal to]16.60, p<0.001), while the risk of false negative test was significantly lower among cases with fever (axillary temperature [greater than or equal to]37.5oC) (OR [less than or equal to]0.63, p[less than or equal to]0.027). The risk of false positive RDT (as a determinant of specificity) was significantly higher in cases with fever compared to afebrile cases (OR[greater than or equal to]2.40, p<0.001). Using RDTs reduced anti-malarials dispensing from 98.9% to 32.1% in cases aged [greater than or equal to]5 years.
Conclusion
Although RDTs had low sensitivity and specificity, which varied widely depending on fever and parasite density, using RDTs reduced over-treatment with anti-malarials significantly. Thus, with declining malaria prevalence, RDTs will potentially identify majority of febrile cases with parasites and lead to improved management of malaria and non-malaria fevers.
Saturday, July 16, 2011
A World Without Malaria? It’s Possible!
A World Without Malaria? It’s Possible.
Most people would agree that dying from a mosquito bite in the twenty-first century is an absolute tragedy. Yet, until recently this was largely accepted as an inevitable part of life in large parts of Africa and Asia.Times are changing fast.
Such has been our progress in fighting malaria in the last decade that in the next few years the disease could be eliminated as a public health problem in most endemic countries. This is a realistic possibility if those countries keep expanding malaria prevention and treatment at the pace set in recent years.
The numbers tell a clear story. In 2000, malaria was a neglected disease. Today, at least 11 of the most endemic countries in Africa have shown a reduction of more than 50 percent in confirmed malaria cases or malaria admissions and deaths.
The Global Fund, which accounts for two-thirds of international malaria funding, has been at the heart of this progress. Since the Fund was created in 2002, its resources have enabled the distribution of more than 160 million insecticide-treated nets to prevent malaria. Remarkably, 60 million of these were distributed in 2010 alone.
The massive increase in resources from the Global Fund and other sources over the last few years means that today there are enough nets to cover three-quarters of the African population at risk of malaria.
Nigeria is one country leading the way. Bolstered by Global Fund resources and a concerted effort by the government and other partners, half of the country’s states achieved universal access in bed net coverage by the end of 2010. The rest are expected to do so by the end of this year.
We are now at a critical inflection point. As the world catches its breath with the economic crisis, some donor countries are reducing their overseas development budgets. But if we are to realize our goal of eliminating malaria, the world must commit to finish what has been started. Now, more than ever, is the time to step up the fight against malaria so that no-one dies from that simple but deadly mosquito bite.
Professor Michel Kazatchkine is Executive Director of the Global Fund to Fight AIDS, TB and Malaria.
Friday, July 15, 2011
WHO - Good practices for selecting and procuring rapid diagnostic tests for malaria
Good practices for selecting and procuring rapid diagnostic tests for malaria
OVERVIEW
Publication details
Number of pages: 108
Publication date: 2011
Languages: English
ISBN: 9789241501125
Publication date: 2011
Languages: English
ISBN: 9789241501125
Downloads
This manual, designed as a practical 12-step checklist, provides guidance on the selection and procurement of quality rapid diagnostic tests (RDTs) for malaria. Drawing on the results of the WHO/TDR-FIND-CDC Product Testing Programme, the manual aims to strengthen the capacity of national and international procurement officers. It covers all aspects of the procurement cycle, with special emphasis on product specifications, selection criteria for different epidemiological settings, different quantification methodologies based on malaria surveillance and consumption data, as well as quality control through lot testing.
Source: http://www.who.int/malaria/publications/atoz/9789241501125/en/index.htmlWednesday, July 13, 2011
Roll Back Malaria Progress & Impact Series: Focus on Zambia
Roll Back Malaria Progress & Impact Series:
Focus on Zambia
Photo: David Lwenje, Zambia National Malaria Control Centre
Source: http://www.rollbackmalaria.org/ProgressImpactSeries/report7.html
Through the National Malaria Control Centre (NMCC), Zambia has built up a strong disease-control programme, with well-defined goals and organizational plans.
Sound policies and good planning have attracted both partners and growing resources. Between 2003 and 2010, nearly US$ 200 million in external funding was allocated to scale up the malaria control programme.
These funds, as well as a growing contribution from the Government of Zambia, were used to roll out appropriate preventive and curative services:
- Over six million insecticide-treated mosquito nets (ITNs) were distributed between 2007 and 2010.
- Over one million households have received indoor residual spraying (IRS) annually between 2008 and 2010, protecting at least five million people per year.
- Health personnel have been trained in proper diagnosis and treatment of malaria, using Rapid diagnostic tests (RDT) and Artemisininbased combination therapies (ACT), in all nine provinces—including an expanding number of community health workers.
Careful roll-out of interventions was quickly followed by good coverage results:
- 73% of households had either one or more ITNs or received IRS in 2010— a 41% increase in household availability of malaria prevention nationally between 2006 and 2010 and a fivefold increase between 2001/20021 and 2008.
- 52% of children under five in rural areas and 46% of pregnant women nationwide (regardless of mosquito-net ownership) used an ITN the night before the survey—a more than twofold increase in the same 2006 to 2010 period.
- Among children with fever in the two weeks preceding the survey, 26% received an ACT in 2010 compared with 13% in 2008—a twofold increase in two years.
These coverage results, in turn, allowed health staff to achieve impact, reduce disease burden and save lives:
- The prevalence of parasitaemia in children under five was reduced from 22% in 2006 to 16% in 2010.
- All-cause child mortality decreased by 29% between 2001/2002 and 2007.
- According to the Lives Saved Tool (LiST a model used to estimate impact based on rates of coverage of the various interventions), the lives of 33 000 children under five have been saved by malaria control interventions since 2001.
These data show that malaria control is working and can generate major health gains. However, reductions in funding from 2008 to 2010 have been associated with decreases in intervention coverage in three provinces. This rapidly led to rebounds in parasitaemia and severe anaemia, highlighting the necessity of maintaining human and financial resources to sustain the gains.
Zambia is now aiming at achieving and sustaining high national coverage rates for malaria control interventions. By anticipating the next steps in sustained control and maintaining a focused and organized approach, accompanied by adequate human and financial resources, final malaria control success could be within reach.
BOX 1: The extent of malaria in Zambia
Malaria in Zambia at a glance
- There are 13 million inhabitants in Zambia.
- Malaria is endemic and transmission is stable with a seasonal peak from November to April.
- There are regional epidemiological variations with a decreasing gradient in malaria transmission intensity from the north-east to the south-west.
- In 2007, there were about 4 million suspected cases and 6000 deaths attributable to malaria.
- Malaria is responsible for about 20% of deaths among children under five.
Zambia has a population of approximately 13 million people (Census Statistics Office, 2010). It is administratively divided into 9 provinces and 73 districts.
The entire country is endemic for malaria with moderate-to-high transmission in all districts. A seasonal pattern of higher transmission is associated with the rains between November and April.
Northern, Luapula and Eastern provinces have the highest annual incidence of malaria, while the lowest is found in Lusaka Province, specifically around the capital city.
The predominant malaria parasite species is Plasmodium falciparum. Plasmodium malariae and ovale account for less than 5% of recorded parasitaemia. Anopheles gambiae and Anopheles funestis are the main vectors.
Measuring malaria's contribution to death and disease is challenging. Without proper parasitological confirmation, the diagnosis of malaria relies on non-specific clinical symptoms, mainly fever. Since 2007, RDTs have been made available widely to assist with parasitological confirmation, although the national healthreporting system did not begin to report confirmed cases until 2009.
Regardless, malaria has always placed an overwhelming burden on the Zambian population:
- The annual reported malaria incidence—including confirmed and unconfirmed cases— was estimated at 358 cases per 1000 population in 2007, a decrease from 412 cases per 1000 population in 2006 (MOH, 2008).
- In 2007, 4.3 million cases of malaria (confirmed and unconfirmed) were reported countrywide, with over 6000 deaths attributable to the disease (MOH, 2008).
- Malaria accounts for 40% of all outpatient attendance, for up to 40% of all infant mortality and for 15–20% of deaths in children under five years of age.
The human and economic impact of the disease is a serious curb to economic development, either directly—through the costs of health care and hospitalization—or indirectly, through work-days lost to personal illness or to caring for a sick child. Malaria accounts for 6.8 million disability-adjusted life years lost in Zambia—more than respiratory infections (5.4 million) or HIV/AIDS (3.2 million)
Saturday, April 2, 2011
Book Review: Malaria In Africa By Olaf Muller
Müller, Olaf
Malaria in Africa
Challenges for Control and Elimination in the 21st Century
Series: Challenges in Public Health - Volume 60
Year of Publication: 2011
Frankfurt am Main, Berlin, Bern, Bruxelles, New York, Oxford, Wien, 2011. 193 pp., num. fig. and tables
ISBN 978-3-631-59792-7 hb.
ISBN 978-3-631-59792-7 hb.
Weight: 0.360 kg, 0.794 lbs
Discipline
Book synopsis
About half of the world's population is still at risk for contracting malaria, and the main disease burden is now in sub-Saharan Africa (SSA). As a result of the activities of a number of new and powerful Global Health Initiatives, malaria morbidity and mortality has recently started to decrease and the idea of eradication has re-emerged. This book provides a comprehensive update on the recent developments of the epidemiology of malaria and of existing strategies and tools for malaria control and elimination in Africa, which is discussed in the context of the long global history of malaria control. The main message is that the ambitious Global Malaria Action Plan of RBM will fail without serious efforts to systematically and massively strengthen the health systems of African countries.
Contents
Contents: Malaria History - Malaria in Africa - Epidemiology and Control - Global Burden - Insecticide-Treated Mosquito Nets - Artemisinin-based Combination Therapies - Elimination and Eradication - Millennium Development Goals - Global Health Initiatives - Primary Health Care - Health Systems.
About the author(s)/editor(s)
Olaf Müller, born in 1954; MD (1986) and PhD (1990) Free University of Berlin; MPH (1993) University of Hannover; Habilitation (2004) Heidelberg University; Medical assistant (1987-1991); Researcher and Consultant (1987-1997); since 1997 Senior scientist at the Tropical Institute, Heidelberg University; since 2007 Professor of Public Health at the Institute of Public Health, Heidelberg University.
Series
Challenges in Public Health. Vol. 60
Edited by Oliver Razum
Edited by Oliver Razum
Subscribe to:
Posts (Atom)